KUALA LUMPUR: The National Pharmaceutical Regulatory Agency (NPRA) has confirmed receiving reports of 18 cases of serious adverse events following immunisation (AEFI) among Covid-19 vaccine recipients under the Kajang Prison Vaccination Programme.
Responding to a letter that went viral on social media, NPRA director-general Dr Roshayati Mohamad Sani said the AEFI report was classified as serious as it involved fatalities that are under investigation.
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
